Piramal Enterprises (Delisted) share news and announcements
BSE: 500302Finance
Formerly Piramal Healthcare
Last traded ₹1,124.20 on 22 Sep 2025
Delisted on 16 Jan 2026.
Piramal Enterprises share news and announcements
3,280 announcements, routine notices left out, newest first. Page 64 of 66.
Feb 2010
Jan 2010
21 Jan · Business
Press release dated January 21, 2010, titled "Piramal Healthcare Reports Q3 FY2010 Results; Consolidated Revenues for the quarter up by 9.0% to Rs. 9.1 billion, Operating Profit up by 45.0% to Rs.1.8 billion, Net Profit up by 128% to Rs.1.4 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 90770 lacs for quarter ending on 31-DEC-2009 against Rs. 82833 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 13621 lacs for the quarter ending on 31-DEC-2009 against Rs. 5987 lacs for the quarter ending on 31-DEC-2008.21 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 70489 lacs for quarter ending on 31-DEC-2009 against Rs. 58046 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 13828 lacs for the quarter ending on 31-DEC-2009 against Rs. 3867 lacs for the quarter ending on 31-DEC-2008.13 Jan · Piramal Healthcare - Change in RTA
Share Transfer Agent of the Company is being changed from "M/s. Freedom Registry Ltd. (formerly known as Amtrac Management Services Ltd.)" ....13 Jan · Board meeting
To consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 3rd Quarter ended December 31, 2009. The standalone results shall be subjected to limited review.13 Jan · Results
Meeting of the Board of Directors of the Company will be held on January 21, 2010, to consider and take on record the Unaudited Financial ....13 Jan · Change in Registrar & Share Transfer Agent
The Share Transfer Agent of the Company is being changed from M/s Freedom Registry Limited (formerly known as Amtrac Management Services Limited) to M/s Link Intime India Pvt. Ltd. with effect from 1st February, 2010
Dec 2009
3 Dec · Raising of funds
Vide its letter dated December 03, 2009 that "The Board of Directors of the Company at its meeting today, approved a proposal for raising funds upto an amount of Rs. 1000 crores through an issue of equity/ equity-linked securities, subject to requisite approvals. The duly authorized Committee of Directors has been empowered to take a final decision on the pricing, mode and manner of raising such funds."
Oct 2009
22 Oct · Business
Press release dated October 22, 2009, titled "Piramal Healthcare Reports Q2 FY2010 Results; Consolidated Revenues for the Quarter up by 12.4% to Rs. 10.0 billion, Operating Profit up by 26.1% to Rs.1.8 billion, Net Profit up by 44.8% to Rs.1.0 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 182153 lacs for half year ending on 30-SEP-2009 against Rs. 158856 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 19137 lacs for the half year ending on 30-SEP-2009 against Rs. 14148 lacs for the half year ending on 30-SEP-2008.22 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 99999 lacs for quarter ending on 30-SEP-2009 against Rs. 88425 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 10627 lacs for the quarter ending on 30-SEP-2009 against Rs. 7339 lacs for the quarter ending on 30-SEP-2008.22 Oct · Results
Standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 127743 lacs for half year ending on 30-SEP-2009 against Rs. 111729 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 18833 lacs for the half year ending on 30-SEP-2009 against Rs. 12038 lacs for the half year ending on 30-SEP-2008.22 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 70770 lacs for quarter ending on 30-SEP-2009 against Rs. 63197 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 11422 lacs for the quarter ending on 30-SEP-2009 against Rs. 6944 lacs for the quarter ending on 30-SEP-2008.12 Oct · Board meeting
To consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 2nd Quarter and half-year ended September 30, 2009.
Sep 2009
14 Sep · Legal
With reference to the earlier announcement dated September 10, 2009 on Pledge of Shares - Disclosure u/s 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997 as follows: "In view of the queries being received and to avoid confusion, we wish to clarify that the total shares pledged by the entity viz. PHL Holdings Pvt Ltd (i.e.84,20,000 shares), which is one of the constituents of the Promoter Group, constitute only 8.13% of the Promoter Group Shareholding in Piramal Healthcare Limited".
Aug 2009
25 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
22 Jul · Business
Press release dated July 22, 2009, titled "Piramal Healthcare Reports Q1 FY2010 Results; Consolidated Revenues up for the Quarter by 16.0% to Rs. 8.2 billion, Operating Profit up by 34.0% to Rs.1.6 billion, Net Profit up by 25.0% to Rs.851.0 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 56973 lacs for quarter ending on 30-JUN-2009 against Rs. 48912 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 7411 lacs for the quarter ending on 30-JUN-2009 against Rs. 5094 lacs for the quarter ending on 30-JUN-2008.22 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 82154 lacs for quarter ending on 30-JUN-2009 against Rs. 70832 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 8510 lacs for the quarter ending on 30-JUN-2009 against Rs. 6809 lacs for the quarter ending on 30-JUN-2008.13 Jul · Board meeting
To consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 1st Quarter ended June 30, 2009.
Jun 2009
23 Jun · Meeting
Outcome of Annual General Meeting held on June 18, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
22 May · Change of name of Share Transfer Agent
The name of our Share Transfer Agent has been changed from 'Amtrac Management Services Limited' to 'Freedom Registry Limited' with effect from April 16, 2009
Apr 2009
24 Apr · Meeting
Board of Directors at its meeting held on April 24, 2009 has fixed the date for the Annual General Meeting of the Company on June 18, 2009. Further the Register of Members and Share Transfer Books shall remain closed from June 9, 2009 to June 18, 2009 (both days inclusive) for the purpose of payment of dividend.24 Apr · Business
Press release dated April 24, 2009, titled "Revenues for FY2009 up by 14.4% to Rs.32.8 billion, EBITDA (excluding FOREX impact) for the year was up by 23.7% at Rs.6.7 billion and Net Profit (excluding FOREX impact) was up by 23.5% to Rs 4.4 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Apr · Dividend
Board of Directors of the Company at its meeting held on April 24, 2009 has recommended dividend @ 210% (i.e. Rs.4.20 per equity share of face value of Rs.2/- each) for the financial year ended March 31, 2009.24 Apr · Results
Standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 233346 lacs for year ending on 31-MAR-2009 against Rs. 193002 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 27532 lacs for the year ending on 31-MAR-2009 against Rs. 30148 lacs for the year ending on 31-MAR-2008.24 Apr · Results
Standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 62297 lacs for quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 11627 lacs for the quarter ending on 31-MAR-2009.24 Apr · Results
Consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 328110 lacs for year ending on 31-MAR-2009 against Rs. 287284 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 31625 lacs for the year ending on 31-MAR-2009 against Rs. 33378 lacs for the year ending on 31-MAR-2008.24 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 85091 lacs for quarter ending on 31-MAR-2009 against Rs. 76787 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 11490 lacs for the quarter ending on 31-MAR-2009 against Rs. 13282 lacs for the quarter ending on 31-MAR-2008.16 Apr · Board meeting
To consider and approve the Audited Financial Results (stand-alone & consolidated) of the Company for the financial year ended March 31, 2009. Further the Board would also consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2009.2 Apr · Updates
As a part of consolidation of global manufacturing assets, Piramal Healthcare has decided to discontinue operations at its manufacturing facility in Huddersfield, UK. This is an Intermediate/API site catering to the Pharma Solutions (Custom Manufacturing) business and is one of the manufacturing sites of Piramal Healthcare (UK) Ltd., the Company's wholly-owned subsidiary in the UK. In 2005, Piramal Healthcare acquired Avecia Pharmaceuticals which was then renamed as NPIL Pharmaceuticals (UK) Ltd. (now known as Piramal Healthcare (UK) Ltd.). The Company had manufacturing facilities in Huddersfield. Grangemouth (Scotland) and Toronto (Canada). The remaining two sites at Grangemouth and Toronto will continue to operate and drive growth for the Pharma Solutions business. The closure will result in a one time cash cost of approximately Rs. 70 crores which will be incurred in the year ended March 31, 2009. As a result of this closure and increased acceptance of India as a custom manufacturing destination, profitability of the Pharma Solutions business is expected to increase significantly1 Apr · Management
Ms Nandini Piramal has been appointed as an Executive Director on the Board of the Company. Ms.Nandini Piramal is the daughter of Mr. Ajay Piramal and Dr. Swati Piramal and belongs to the Promoter Group. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2009
2 Mar · Business
Press release dated February 28, 2009 titled "Piramal Healthcare Limited Completes Acquisition of Minrad International, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
26 Feb · News Verification
News Verification : The media had reports that Sanofi-Aventis may buy a substantial stake in the company. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Piramal Healthcare Limited has vide its letter inter-alia stated,"We would like to clarify that the promoter has no intention to dilute current ownership levels."9 Feb · Press Statement
"The Company clarifies that speculation in certain sections of the media about a potential sale of the company is totally unfounded". Further, the Company has submitted to the Exchange a press statement in this regard. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
28 Jan · Business
Press release dated January 28, 2009, titled "Piramal Healthcare Limited Acquires U.S. Inhalation Anesthetic Gas Distribution Business of RxElite, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jan · Business
Press release dated January 22, 2009, titled "Piramal Healthcare reports Q3 FY2009 results; Consolidated revenues for the quarter up by 14.9% to Rs. 8.3 billion, Operating profit (excluding FOREX impact) up by 40.6% to Rs. 1.6 billion, Net Profit (before FOREX impact) up by 29.3% to Rs. 918.9 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 58046 lacs for quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 3867 lacs for the quarter ending on 31-DEC-2008.22 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 82833 lacs for quarter ending on 31-DEC-2008 against Rs. 73233 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 5987 lacs for the quarter ending on 31-DEC-2008 against Rs. 7264 lacs for the quarter ending on 31-DEC-2007.13 Jan · Board meeting
To consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 3rd quarter ended December 31, 2008.
Dec 2008
23 Dec · Business
Press release dated December 23, 2008, titled "Piramal Healthcare Limited to acquire Minrad International, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
22 Oct · Business
Press release dated October 22, 2008, titled "Piramal Healthcare reports Q2 FY2009 results; Consolidated Revenues for the quarter up by 17% to Rs.8.9 billion, Operating Profit (excluding FOREX impact) up by 41% to Rs.1.8 billion, Net Profit (before FOREX impact and exceptional items) up by 40% to Rs.1.2 billion. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Oct · Results
Consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 158856 lacs for half year ending on 30-SEP-2008 against Rs. 137264 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 14148 lacs for the half year ending on 30-SEP-2008 against Rs. 12821 lacs for the half year ending on 30-SEP-2007.22 Oct · Results
Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 63197 lacs for quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 6944 lacs for the quarter ending on 30-SEP-2008.